Development of a ‘mouse and human cross-reactive’ affinity-matured exosite inhibitory human antibody specific to TACE (ADAM17) for cancer immunotherapy

Publication: Protein Eng. Des. Sel.. March 2014. 27:179 PMID: 24769623. Authors: Kwok HF, Botkjaer KA, Tape CJ, McCafferty J, Murphy G